Evidence map›Paper›PMID 24980432›Full record

ArticleMolecular and cellular biology2014

Chromatin profiling reveals regulatory network shifts and a protective role for hepatocyte nuclear factor 4α during colitis.

Sanjay Chahar, Vishal Gandhi, Shiyan Yu, Kinjal Desai, Richard Cowper-Sal-lari, Yona Kim, Ansu O Perekatt, Namit Kumar, Joshua K Thackray, Anthony Musolf and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Early subclinical stages of the inflammatory bowel diseases: insights from human and animal studies.American journal of physiology. Gastrointestinal and liver physiology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Sanjay ChaharHuman Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA.
Vishal GandhiHuman Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA.
Shiyan YuDepartment of Biological Sciences, Rutgers, the State University of New Jersey, Newark, New Jersey, USA.
Kinjal DesaiDepartment of Genetics, Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire, USA.
Richard Cowper-Sal-lariThe Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
Yona KimHuman Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA.
Ansu O PerekattHuman Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA.
Namit KumarHuman Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA.
Joshua K ThackrayHuman Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA.
Anthony MusolfHuman Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA.
Nikhil KumarHuman Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA.
A HoffmanHuman Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA.
Douglas LondonoHuman Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA.
Berta N VazquezHuman Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA.
Lourdes SerranoHuman Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA.
Hyunjin ShinDepartment of Translational Medicine, Takeda Pharmaceuticals International, Inc., Cambridge, Massachusetts, USA.
Mathieu LupienThe Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada Ontario Institute for Cancer Research, Toronto, ON, Canada.
Nan GaoDepartment of Biological Sciences, Rutgers, the State University of New Jersey, Newark, New Jersey, USA Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Michael P VerziHuman Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA verzi@biology.rutgers.edu.
Rutgers, The State University of New Jersey · USPrincess Margaret Cancer Centre · CARutgers Cancer Institute of New JerseyDartmouth College · USTakeda (United States) · US

Funding

Breast and prostate cancer risk SNPs regulate FoxA1 and nuclear receptor activityR01CA155004 · NCI · UNIVERSITY HEALTH NETWORK · PI LUPIEN, MATHIEU · 2011 to 2015
$1.2M
Transcriptional Regulation of the Intestinal EpitheliumK01DK088868 · NIDDK · RUTGERS, THE STATE UNIV OF N.J. · PI VERZI, MICHAEL P. · 2010 to 2014
$740k
Regulation of Apical-Basal Cell polarity during Intestinal Epithelial MorphogenesK01DK085194 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GAO, NAN · 2010 to 2014
$728k
CIHRNCI NIH HHS R01 CA155004NIDDK NIH HHS K01 DK085194NIDDK NIH HHS K01 DK088868NIDDK NIH HHS K01DK088868
6 · The paper itself

Abstract

Transcriptional regulatory mechanisms likely contribute to the etiology of inflammatory bowel disease (IBD), as genetic variants associated with the disease are disproportionately found at regulatory elements. However, the transcription factors regulating colonic inflammation are unclear. To identify these transcription factors, we mapped epigenomic changes in the colonic epithelium upon inflammation. Epigenetic marks at transcriptional regulatory elements responded dynamically to inflammation and indicated a shift in epithelial transcriptional factor networks. Active enhancer chromatin structure at regulatory regions bound by the transcription factor hepatocyte nuclear factor 4α (HNF4A) was reduced during colitis. In agreement, upon an inflammatory stimulus, HNF4A was downregulated and showed a reduced ability to bind chromatin. Genetic variants that confer a predisposition to IBD map to HNF4A binding sites in the human colon cell line CaCo2, suggesting impaired HNF4A binding could underlie genetic susceptibility to IBD. Despite reduced HNF4A binding during inflammation, a temporal knockout model revealed HNF4A still actively protects against inflammatory phenotypes and promotes immune regulatory gene expression in the inflamed colonic epithelium. These findings highlight the potential for HNF4A agonists as IBD therapeutics.

Indexed as

Gene Regulatory NetworksAnimalsBinding SitesCaco-2 CellsChromatinColitisDextran SulfateDisease Models, AnimalEpigenesis, GeneticFemaleGene Knockout TechniquesGenetic Predisposition to DiseaseHepatocyte Nuclear Factor 4HumansInflammatory Bowel DiseasesIntestinal MucosaChromatinDextran SulfateHepatocyte Nuclear Factor 4HNF4A protein, humanHnf4a protein, mouse

Identifiers

PMID24980432
PMCPMC4135557
OpenAlexW2138319875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.